Hao Ding

523 total citations
33 papers, 372 citations indexed

About

Hao Ding is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao Ding has authored 33 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao Ding's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and RNA modifications and cancer (4 papers). Hao Ding is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and RNA modifications and cancer (4 papers). Hao Ding collaborates with scholars based in China, United States and Australia. Hao Ding's co-authors include Weifeng Tang, Pamela T. Wong, Hao Qiu, Ari Gafni, D. G. Steel, Changqing Zhang, Weitao Jia, Guangyi Li, Jun Yin and Haiyong Gu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Hao Ding

31 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Ding China 12 157 86 56 56 53 33 372
Takuto Shimizu Japan 12 168 1.1× 94 1.1× 137 2.4× 55 1.0× 49 0.9× 56 432
Eleanor Knopp United States 10 151 1.0× 84 1.0× 73 1.3× 20 0.4× 38 0.7× 17 445
Andreas Giannakou United States 12 200 1.3× 145 1.7× 137 2.4× 56 1.0× 65 1.2× 25 533
Chung‐Chieh Wang Taiwan 13 215 1.4× 127 1.5× 85 1.5× 23 0.4× 85 1.6× 24 423
Eva Brčáková Czechia 13 94 0.6× 127 1.5× 81 1.4× 52 0.9× 18 0.3× 20 366
Haifeng Wang China 10 153 1.0× 53 0.6× 98 1.8× 28 0.5× 62 1.2× 43 357
Roberto Caporale Italy 11 135 0.9× 69 0.8× 66 1.2× 53 0.9× 37 0.7× 25 402
Veronika Jekerle Netherlands 8 208 1.3× 211 2.5× 136 2.4× 36 0.6× 45 0.8× 11 552
Wei‐Xia Peng Japan 15 236 1.5× 128 1.5× 91 1.6× 28 0.5× 106 2.0× 34 576

Countries citing papers authored by Hao Ding

Since Specialization
Citations

This map shows the geographic impact of Hao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Ding more than expected).

Fields of papers citing papers by Hao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Ding. The network helps show where Hao Ding may publish in the future.

Co-authorship network of co-authors of Hao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Ding. A scholar is included among the top collaborators of Hao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Ding. Hao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Lingling, Lifang Chen, Xin Chen, et al.. (2025). Exosomal FGG promotes colorectal cancer liver metastases through inducing angiogenic pre-metastatic niche formation. Archives of Biochemistry and Biophysics. 774. 110625–110625.
3.
Zhu, Li, Qiang Zheng, Hao Ding, et al.. (2025). HMGB1 lactylation drives neutrophil extracellular trap formation in lactate-induced acute kidney injury. Frontiers in Immunology. 15. 1475543–1475543. 13 indexed citations
4.
Hu, Song, et al.. (2024). A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer. Frontiers in Oncology. 14. 1314301–1314301. 2 indexed citations
5.
Ding, Hao, et al.. (2024). Circ_0001361/miR-490-5p/IGF2 Axis Regulates the Viability and Apoptosis of Neuroblastoma Cells. Neurochemical Research. 49(11). 3060–3068. 2 indexed citations
6.
Su, Chang, et al.. (2024). Small molecules for inflammatory bowel disease and the risk of infection and malignancy: A systematic review and meta-Analysis. Digestive and Liver Disease. 56(11). 1828–1838. 3 indexed citations
7.
Shemesh, Colby S., Yongsheng Wang, Andrew An, et al.. (2023). Abstract CT266: Chinese race and origin have no clinically meaningful effect on tiragolumab and atezolizumab pharmacokinetics and safety in patients with advanced solid tumors. Cancer Research. 83(8_Supplement). CT266–CT266. 1 indexed citations
8.
Ding, Hao, et al.. (2022). The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients. Cancer Biomarkers. 35(1). 119–125. 1 indexed citations
9.
Shao, Lin, et al.. (2021). Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report. OncoTargets and Therapy. Volume 14. 3063–3067. 4 indexed citations
10.
Ding, Hao, Ke Hu, Pei Liu, et al.. (2020). Hypoxia in�utero increases the risk of pulmonary hypertension in rat offspring and is associated with vasopressin type‑2 receptor upregulation. Molecular Medicine Reports. 22(5). 4173–4182. 9 indexed citations
11.
Lu, Tong, Grace Ku, Hao Ding, et al.. (2020). Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Cancer Chemotherapy and Pharmacology. 86(3). 347–359. 6 indexed citations
12.
13.
14.
15.
Zhu, Li, Zhiqiang Xie, Hao Qiu, et al.. (2017). TCF7L2 rs290481 T>C polymorphism is associated with an increased risk of type 2 diabetes mellitus and fasting plasma glucose level. Oncotarget. 8(44). 77000–77008. 8 indexed citations
16.
Ding, Hao, et al.. (2017). Research on the A549 cell apoptosis mechanism of the nude mouse model using MenSC-sTRAIL.. PubMed. 21(14). 3218–3222. 3 indexed citations
17.
Tang, Weifeng, Hao Qiu, Hao Ding, et al.. (2013). Association between the STK15 F31I Polymorphism and Cancer Susceptibility: A Meta-Analysis Involving 43,626 Subjects. PLoS ONE. 8(12). e82790–e82790. 40 indexed citations
18.
Yan, Yulan, Liu Yang, Taofeng Zhu, et al.. (2012). Inhibition of Lung Adenocarcinoma Transfected with Interleukin 28A Recombinant Adenovirus (Ad-mIFN-λ 2 ) In Vivo. Cancer Biotherapy and Radiopharmaceuticals. 28(2). 124–130. 11 indexed citations
19.
Li, Guangyi, et al.. (2012). Efficacy of leukocyte‐ and platelet‐rich plasma gel (L‐PRP gel) in treating osteomyelitis in a rabbit model. Journal of Orthopaedic Research®. 31(6). 949–956. 48 indexed citations
20.
Ding, Hao, et al.. (2009). Determination of the Oligomer Size of Amyloidogenic Protein β-Amyloid(1–40) by Single-Molecule Spectroscopy. Biophysical Journal. 97(3). 912–921. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuto Shimizu Breakdown of academic impact, for papers by Eleanor Knopp Breakdown of academic impact, for papers by Andreas Giannakou Breakdown of academic impact, for papers by Chung‐Chieh Wang Breakdown of academic impact, for papers by Eva Brčáková Breakdown of academic impact, for papers by Haifeng Wang Breakdown of academic impact, for papers by Roberto Caporale Breakdown of academic impact, for papers by Veronika Jekerle Breakdown of academic impact, for papers by Wei‐Xia Peng
Rankless by CCL
2026